Advertisement
Screener

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of GBP 0.8 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2019-02-27

  • ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2018 was 0.80 GBP.

GBP

Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month
2018-12-310.80 GBP
10-K · filed 2019-02-27

USD/shares

Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month
2017-12-31$1.04
10-K · filed 2018-03-15
2016-12-31$1.04
10-K · filed 2017-03-13
2015-12-31$0.59
8-K · filed 2016-07-08
2015-06-30$0.53
8-K · filed 2016-07-08

GBP/shares

Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month
2018-12-310.80 GBP/shares
10-K · filed 2019-02-27